MiniMed Group Quarterly Income Statement
NASDAQ: MMEDHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
MiniMed Group revenue and earnings
In the quarter ended Jul 31, 2026, MiniMed Group generated $843.0 million in revenue, up 16.6% from the same quarter a year earlier. Net income was $0, for a net margin of 0.0% versus a median of -18.6% in the prior 5 quarters. Gross margin was 55.2% (down from 56.6%) and operating margin 0.6%.
Diluted earnings per share came in at $0.00.
Summary generated from market data by MetaCap's automated system. Methodology
MiniMed Group income statement (quarterly)
| Quarter (USD) | Q1 20272026-07-31 | Q4 20262026-04-24 | Q3 20262026-01-23 | Q2 20262025-10-24 | Q1 20262025-07-25 | Q4 20252025-04-25 | Q3 20252025-01-24 | Q2 20252024-10-25 | Q1 20252024-07-26 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 843.00M | 837.00M | 790.00M | — | 723.00M | 724.00M | 687.00M | — | — |
| Revenue growth (YoY) | +16.60% | +15.61% | +14.99% | — | — | — | — | — | — |
| Cost of Revenue | 378.00M | 357.00M | 428.00M | — | 314.00M | 318.00M | 292.00M | — | — |
| Gross Profit | 465.00M | 480.00M | 362.00M | — | 409.00M | 405.00M | 395.00M | — | — |
| Operating Expenses | 460.00M | 573.00M | 462.00M | — | 422.00M | 553.00M | 374.00M | — | — |
| Research & Development | 115.00M | 99.00M | 114.00M | — | 125.00M | 107.00M | 112.00M | — | — |
| Selling, General & Admin | 312.00M | 299.00M | 309.00M | — | 283.00M | 276.00M | 268.00M | — | — |
| Operating Income | 5.00M | -93.00M | -100.00M | — | -13.00M | -148.00M | 21.00M | — | — |
| Other Income (Expense) | 0 | 1.00M | 0 | — | 0 | 0 | 0 | — | — |
| Pretax Income | 4.00M | -92.00M | -99.00M | — | -13.00M | -148.00M | 21.00M | — | — |
| Income Tax | 4.00M | 93.00M | 12.00M | — | 3.00M | 21.00M | 28.00M | — | — |
| Net Income | 0 | -185.00M | -119.00M | -5.00M | -19.00M | -172.00M | -10.00M | -5.00M | -19.00M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — |
| EPS (Basic) | 0.00 | — | -0.47 | — | -0.08 | — | -0.04 | — | — |
| EPS (Diluted) | 0.00 | — | -0.47 | — | -0.08 | — | -0.04 | — | — |
| Shares Outstanding (Basic) | 281.00M | — | 252.81M | — | 252.80M | — | 252.81M | — | — |
| Shares Outstanding (Diluted) | 281.00M | — | 252.81M | — | 252.80M | — | 252.81M | — | — |
| EBITDA | 46.00M | -54.00M | — | — | 26.00M | -110.00M | — | — | — |
| Gross Margin | 55.16% | 57.35% | 45.82% | — | 56.57% | 55.94% | 57.50% | — | — |
| Operating Margin | 59.00% | -11.11% | -12.66% | — | -1.80% | -20.44% | 3.06% | — | — |
| Net Margin | 0.00% | -22.10% | -15.06% | — | -2.63% | -23.76% | -146.00% | — | — |
This table shows 9 quarterly periods of MiniMed Group's income statement, from Q1 2027 back to Q1 2025, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow MMED's reporting calendar. What is a income statement?